COMMUNIQUÉS West-GlobeNewswire

Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
12/03/2026
Nominated KRRO-121 development candidate for the potential treatment of hyperammonemia in patients with urea cycle disorders and hepatic encephalopathy Advanced GalNAc-conjugated oligonucleotide for alpha-1 antitrypsin [...]
Plus Therapeutics Reports 2025 Results, Business Progress and 2026 Anticipated Milestones for REYOBIQ™ Clinical Program and CNSide® Commercial Rollout
12/03/2026
HOUSTON, March 12, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for [...]
Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update
12/03/2026
– Announced FDA acceptance of NDA for lorundrostat in adults with hypertension; assigned PDUFA target date of December 22, 2026 – – Conference call today at 4:30 p.m. ET – RADNOR, Pa., March 12, 2026 (GLOBE NEWSWIRE [...]
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
12/03/2026
TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA to patients, [...]
Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
12/03/2026
MOUNTAIN VIEW, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for [...]
Voting Rights and Shares Capital of the Company
12/03/2026
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, March 12, 2026 (GLOBE NEWSWIRE [...]
Vaxart Provides Business Update and Reports Full Year 2025 Financial Results
12/03/2026
Topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial anticipated early Q2 2026 Published positive clinical results in the first quarter of 2026 demonstrating oral norovirus vaccine candidate was [...]
Cellectis publiera ses résultats financiers du quatrième trimestre et de l’année 2025 le 19 mars 2026
12/03/2026
NEW YORK, 12 mars 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome TALEN® pour développer [...]
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
12/03/2026
Presented updated glioblastoma (“GBM”) data demonstrating durable survival and a favorable safety profile across Phase 1 and Phase 2 programs, with repeat dosing of DeltEx™ Drug-Resistant Immunotherapy γδ T cells (“DRI [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
12/03/2026
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 12 mars 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
12/03/2026
First-in-class immune-stimulating antibody conjugate BDC-4182 in Phase 1 dose escalation study, initial clinical data expected in 3Q 2026 Cash balance of $31.8 million as of December 31, 2025 anticipated to fund key [...]
Aeroflow Health Earns 2026 Great Place To Work Certification™
12/03/2026
ASHEVILLE, N.C., March 12, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health is proud to be Certified™ by Great Place To Work®. The prestigious award is based entirely on what current employees say about their experience working [...]
SK pharmteco annonce la certification CGMP de son site de production de vecteurs viraux à échelle commerciale en France
12/03/2026
RANCHO CORDOVA, Californie, 12 mars 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé aujourd'hui le succès de la certification CGMP de son usine de fabrication à Corbeil-Essonnes, en France. Cette usine de pointe est [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - FEVRIER 2026
12/03/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
12/03/2026
COPENHAGEN, Denmark, March 12, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial [...]
Koelis annonce, à l’occasion du Congrès de l’EAU 2026, des innovations technologiques destinées à optimiser les flux de travail de biopsie par fusion IRM et à soutenir le développement de la thérapie focale dans la prise en charge du cancer de la prostate
12/03/2026
GRENOBLE, France, 12 mars 2026 (GLOBE NEWSWIRE) -- Koelis, SAS (« Koelis » ou la « Société », www.koelis.com ), leader technologique et acteur innovant dans le domaine du guidage par fusion IRM-échographie appliqué aux [...]
Sanofi: Information concerning the total number of voting rights and shares - February 2026
12/03/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Rakovina Therapeutics Announces Extension of Non-Brokered Private Placement
12/03/2026
VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through [...]
Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference
12/03/2026
CINCINNATI, March 12, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 36th Annual Healthcare Conference on Thursday, March 19, 2026, [...]

Pages